Both in Lab Analytical Instruments
Bio-Rad Laboratories vs Illumina
Over the past year BIO returned +17.6% and ILMN returned +88.8%; their daily moves had a correlation of 0.33.
BIO +17.6% ILMN +88.8%Growth of $1, one year, split-adjusted
| Metric | BIO | ILMN |
|---|---|---|
| Price | $366.16 | $226.58 |
| Market cap | $9.79B | $34.21B |
| Today | −1.62% | −3.99% |
| 1 month | −0.8% | −17.0% |
| 6 months | +42.0% | +62.6% |
| Year to date | +20.8% | +72.8% |
| 1 year | +20.2% | +128.8% |
| Revenue growth (YoY) | −0.1% | +4.2% |
| Gross margin | 53.1% | 73.5% |
| Net margin | 57.1% | 19.5% |
| P/E (TTM) | 44.0× | 38.2× |
| Price / sales | 3.8× | 7.5× |
| Net cash | $414.8M | -$452.0M |
| Dividend yield | — | — |
| Volatility (60d) | 27.4% | 66.9% |
| Short % of float | 5.9% | 5.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).